BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29860329)

  • 1. Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.
    Schifani C; Tseng HH; Kenk M; Tagore A; Kiang M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Brain; 2018 Jul; 141(7):2213-2224. PubMed ID: 29860329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis.
    Schifani C; Pruessner J; Tseng HH; Rao N; Tagore A; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Addict Biol; 2020 Jul; 25(4):e12812. PubMed ID: 31389139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Prefrontal Cortical Dopamine Release in Schizophrenia During a Cognitive Task: A [11C]FLB 457 Positron Emission Tomography Study.
    Rao N; Northoff G; Tagore A; Rusjan P; Kenk M; Wilson A; Houle S; Strafella A; Remington G; Mizrahi R
    Schizophr Bull; 2019 Apr; 45(3):670-679. PubMed ID: 29878197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prefrontal cortical dopamine release in clinical high risk for psychosis during a cognitive task: a [
    Tagore A; Schifani C; Rao N; Tseng HH; Zakzanis KK; Rusjan PM; Houle S; Mizrahi R
    Eur Neuropsychopharmacol; 2019 Sep; 29(9):1023-1032. PubMed ID: 31351843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.
    Schifani C; Hafizi S; Tseng HH; Gerritsen C; Kenk M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Schizophr Res; 2019 Nov; 213():80-86. PubMed ID: 30409695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
    Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
    JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prefrontal and Striatal Dopamine Release Are Inversely Correlated in Schizophrenia.
    Frankle WG; Himes M; Mason NS; Mathis CA; Narendran R
    Biol Psychiatry; 2022 Nov; 92(10):791-799. PubMed ID: 35791965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.
    Bertolino A; Knable MB; Saunders RC; Callicott JH; Kolachana B; Mattay VS; Bachevalier J; Frank JA; Egan M; Weinberger DR
    Biol Psychiatry; 1999 Mar; 45(6):660-7. PubMed ID: 10187995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in amphetamine-induced dopamine release in the dorsolateral prefrontal cortex of tobacco smokers.
    Zakiniaeiz Y; Hillmer AT; Matuskey D; Nabulsi N; Ropchan J; Mazure CM; Picciotto MR; Huang Y; McKee SA; Morris ED; Cosgrove KP
    Neuropsychopharmacology; 2019 Dec; 44(13):2205-2211. PubMed ID: 31269510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia.
    Frankle WG; Paris J; Himes M; Mason NS; Mathis CA; Narendran R
    Biol Psychiatry; 2018 Apr; 83(8):707-714. PubMed ID: 29325847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine.
    Smith CT; Dang LC; Cowan RL; Kessler RM; Zald DH
    Neuropharmacology; 2016 Sep; 108():394-402. PubMed ID: 27174408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex.
    Lataster J; Collip D; Ceccarini J; Hernaus D; Haas D; Booij L; van Os J; Pruessner J; Van Laere K; Myin-Germeys I
    Schizophr Bull; 2014 Jan; 40(1):66-77. PubMed ID: 23363687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia.
    Bertolino A; Breier A; Callicott JH; Adler C; Mattay VS; Shapiro M; Frank JA; Pickar D; Weinberger DR
    Neuropsychopharmacology; 2000 Feb; 22(2):125-32. PubMed ID: 10649825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
    Kegeles LS; Abi-Dargham A; Frankle WG; Gil R; Cooper TB; Slifstein M; Hwang DR; Huang Y; Haber SN; Laruelle M
    Arch Gen Psychiatry; 2010 Mar; 67(3):231-9. PubMed ID: 20194823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia.
    Tseng HH; Watts JJ; Kiang M; Suridjan I; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Schizophr Bull; 2018 Apr; 44(3):542-551. PubMed ID: 29036383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of striatal dopamine D
    Veselinović T; Vernaleken I; Janouschek H; Cumming P; Paulzen M; Mottaghy FM; Gründer G
    Psychopharmacology (Berl); 2018 Aug; 235(8):2221-2232. PubMed ID: 29717334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis.
    Plavén-Sigray P; Ikonen Victorsson P; Santillo A; Matheson GJ; Lee M; Collste K; Fatouros-Bergman H; Sellgren CM; Erhardt S; Agartz I; Halldin C; Farde L; Cervenka S
    Mol Psychiatry; 2022 Feb; 27(2):1233-1240. PubMed ID: 34759359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine cue-induced dopamine release in the human prefrontal cortex.
    Milella MS; Fotros A; Gravel P; Casey KF; Larcher K; Verhaeghe JA; Cox SM; Reader AJ; Dagher A; Benkelfat C; Leyton M
    J Psychiatry Neurosci; 2016 Aug; 41(5):322-30. PubMed ID: 26900792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task.
    Suridjan I; Rusjan P; Addington J; Wilson AA; Houle S; Mizrahi R
    J Psychiatry Neurosci; 2013 Mar; 38(2):98-106. PubMed ID: 23010256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.
    Kubota M; Nagashima T; Takano H; Kodaka F; Fujiwara H; Takahata K; Moriguchi S; Kimura Y; Higuchi M; Okubo Y; Takahashi H; Ito H; Suhara T
    Int J Neuropsychopharmacol; 2017 Nov; 20(11):928-935. PubMed ID: 29016872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.